NCT04933643

Brief Summary

The invention of magnetically controlled capsule gastroscopy makes the movement of capsule endoscope in the body controllable. Endoscopic doctors can adjust the angle of capsule observation to examine gastric mucosa according to the need of examination. However, The presence of food residue, air bubbles, mucus and bile in the gastric cavity will affect the observation of gastric mucosa by capsule endoscopy. it will reduce the completion rate of capsule endoscopy, and even lead to misdiagnosis and missed diagnosis. The purpose of this study is to explore the factors affecting the quality of gastroscopy gastric environmental preparation of magnetically capsule.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
240

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 19, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 22, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

June 22, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2022

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
Last Updated

February 3, 2023

Status Verified

February 1, 2023

Enrollment Period

1.1 years

First QC Date

May 19, 2021

Last Update Submit

February 2, 2023

Conditions

Keywords

Magnetically Controlled Capsule GastroscopyInfluencing FactorsGastric Preparation Quality

Outcome Measures

Primary Outcomes (2)

  • GCS score was used to evaluate the quality of gastric preparation

    GCS score was used to evaluate the quality of gastric preparation. GCS was defined as the sum of the scores of six major anatomical markers of the stomach (heart, fundus, body, horn, sinus, and pylorus).A 4-point grading system was used to define cleanliness as excellent (no mucus and foam attachment :4 points);Good (there is a small amount of mucus and foam, but it does not affect the test: score 3 points);Average (with a fair amount of mucus or foam).Failure to complete a completely reliable examination :2 points);Poor (large amount of mucus or foam residue :1 point).The GCS is the total score for all six landmarks, ranging from 6 (completely unprepared) to 24 (perfect).Gastric preparation was defined as sufficient when GCS≥18 and insufficient when GCS\<18.

    24 months

  • Questionnaire data were used to analyze the influencing factors

    Before the examination, the subjects were required to fill in a questionnaire about the influencing factors of the quality of stomach preparation. According to GCS, the subjects were divided into fully prepared group and inadequately prepared group. Finally, statistical analysis was used to find the influencing factors that had statistical significance with the quality of stomach preparation according to the questionnaire content.

    24 months

Secondary Outcomes (2)

  • The number of positive lesions

    24 months

  • Number of participants with treatment-related adverse events as assessed by CTCAE v5.0

    24 months

Study Arms (2)

well prepared

GCS was the total scores of all six land-marks, ranging from 6 (completely unprepared) to 24 (perfect). We define that the stomach is well prepared when GCS ≥ 18

inadequate prepared

GCS was the total scores of all six land-marks, ranging from 6 (completely unprepared) to 24 (perfect). We define that GCS \< 18 is inadequate.

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients aged 18-75 years old who intend to undergo magnetron capsule gastroscopy, regardless of gender

You may qualify if:

  • patients aged 18-75 years old who intend to undergo magnetron capsule gastroscopy, regardless of gender
  • sign informed consent form

You may not qualify if:

  • dysphagia, known or suspected gastrointestinal obstruction、stricture and fistula
  • patients with severe somatic diseases unable to complete examination
  • known active upper gastrointestinal bleeding
  • previous history of upper digestive tract or abdominal surgery to change
  • gastrointestinal anatomy
  • patients with cardiac pacemakers or implanted with other electronic medical
  • instruments and magnetic metal foreign bodies
  • pregnant women
  • claustrophobia or other mental disorders uncontrollable

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Gastroenterology, Qilu Hospital, Shandong University

Jinan, Shandong, 250012, China

RECRUITING

Study Officials

  • Li Yanqing

    Qilu Hospital of Shandong University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
2 Weeks
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vice president of QiLu Hospital

Study Record Dates

First Submitted

May 19, 2021

First Posted

June 22, 2021

Study Start

June 22, 2021

Primary Completion

August 1, 2022

Study Completion

March 1, 2023

Last Updated

February 3, 2023

Record last verified: 2023-02

Locations